Candriam Luxembourg S.C.A. »

Forte Biosciences shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Forte Biosciences (FBRX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Forte Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Forte Biosciences held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Forte Biosciences by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.2M 85k 25.90

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Alphabet Cap Stk Cl C (GOOG)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
McKesson Corporation (MCK)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Forte Biosciences

Federated Investors
Fred Alger Management
OrbiMed Advisors
Henderson Group
Affinity Asset Advisors
MPM Oncology Impact Management
Vanguard Group
Vanguard Capital Management
Morgan Stanley
Cable Car Capital
Millennium Management
Adage Capital Partners GP
Woodline Partners
FMR
Citadel Advisors

View all funds holding Forte Biosciences